Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ferguson (Farmington Hills, MI, United States of America), D. Singh (Manchester, United Kingdom), K. Rabe (Grosshansdorf, Germany), M. Jenkins (Cambridge, United Kingdom), M. Patel (Cambridge, United Kingdom), P. Dorinsky (Durham, NC, United States of America). Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial. 792

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for COPD mortality in women in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 463s Year: 2006 Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis Source: Eur Respir Rev, 29 (156) 190166; 10.1183/16000617.0166-2019 Year: 2020 Risk charts of five-year mortality in COPD patients Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Risk factors of death in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Risk factors for mortality in HFNO-treated Covid-19 positive patients – a pilot study Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Predictor factors of mortality in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006 Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Factors associated with mortality in the TORCH trial in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007 Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007 Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019 Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Meta-analysis of FEV1 as a risk factor for all-cause mortality Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020